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Complementary medicine using natural product as antitumor is on the rise. Much research has been performed on Tualang Honey
and it was shown to have therapeutic potential in wound healing, and antimicrobial activity and be antiproliferative against several
cancer models such as human osteosarcoma (HOS), human breast (MCF-7 and MDA-MB-231), and cervical (HeLa) cancer cell
lines. To date, there was limited study on antileukemic properties of Tualang (Koompassia excelsa) Honey. The aim of this study
was to evaluate the antileukemic effect of Tualang Honey on acute and chronic leukemia cell lines. Leukemia cell lines (K562
and MV4-11) and human mononuclear cell isolated from peripheral blood were grown in RPM1 1640 culture medium. The cells
were incubated with increasing concentrations of Tualang Honey. After incubation, the evaluation of viability and apoptosis was
performed. The morphological changes of leukemia cells were the presence of cytoplasmic blebs followed by apoptotic bodies and
round shape of cells. IC
50
against K562 and MV4-11 was determined. Tualang Honey gave 53.9% and 50.6% apoptosis activity on
K562 and MV4-11, respectively, while on human mononuclear cell it was 37.4%. Tualang Honey has the apoptosis-inducing ability
for acute and chronic myeloid leukemia (K562 and MV4-11) cell lines.
1. Introduction
Leukemia is malignant neoplasm of white blood cells orig-
inating from the bone marrow. It is characterized by the
uncontrolled growth of blood cells. Leukemia is classified
into acute and chronic leukemia. Chronic myeloid leukemia
(CML) and acute myeloid leukemia (AML) develop from the
progenitor of myeloid or granulocytic cells. It accounts for
nearly 14.6% of all cases of leukemia in Malaysia [1]. The
current mode of leukemia treatment is using chemotherapy.
However, chemotherapy has its own side effects. The first-
line chemotherapy used to treat CML is imatinib mesylate, a
tyrosine kinase inhibitor. However it is costly and about 50%
developed disease resistance later after treatment [2].
Honey has been used since ancient times for its nutri-
tional and therapeutic value. Many types of honey are
available worldwide and its constituents differ from one place
to another. Tualang Honey (TH) is a local Malaysian honey,
collected from wild honey bees hives on Tualang trees found
in the rain forest. It has been used as a complement to treat
various diseases where its therapeutic value may be related
to its antioxidant properties [3]. In addition, TH also has
been shown to have antibacterial, anticarcinogenic, and anti-
inflammatory activities.
As an antioxidant, it has several preventative effects
against different diseases, such as cancer, coronary dis-
eases, inflammatory disorders, neurological degeneration,
and aging. Increase in phenolic compound in TH may
contribute to its antioxidant property [4].
Previous study reported that galangin and kaempferol
showed their antiproliferative effect on promyelocytic
leukemia cells line (HL60) [5, 6]. The substances such as
polyphenols and phenolic acids found in honey vary
according to the geographical and climatic condition; for
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example, flavanol kaempferol can be found in rosemary
honey and quercetin in sunflower honey. Other study
suggested that quercetin was able to induce apoptosis in
leukemia K562 cell [7].
To the best of our knowledge there is limited study on
the antileukemic effect of TH; thus our aim was to study its
apoptosis activity on acute and chronic leukemia cell lines.
2. Material and Methods
2.1. Cell Culture. Both acute and chronic human leukemia
cell lines (K562 and MV4-11, resp.) were purchased from
ATCC, USA. These cell lines K562 originated from patient
diagnosed as chronic myeloid leukemia and MV4-11 from
an acute myelomonocytic leukemia patient. The base
medium for this cell line was RPMI 1640, added with fetal
bovine serum to a final concentration of 10%, penicillin-
streptomycin (pen-strep) 1%. The cell has been cultured with
air humidity, 95%; carbon dioxide (CO
2
) 5%; and consistency
of temperature at 37.0∘C. Cultures are maintained by the
addition or replacement of fresh medium. The number of
cells seeded for cultures was 1 × 105 viable cells/mL and
subcultured at 1 × 106 cells/mL. The medium was renewed
every 2 to 3 days.
2.2. Isolation of Mononuclear Cells. Mononuclear cells were
grown as primary cell line and function as negative control for
this study.The cellswere isolated by FicollHypaque technique
from 5mL of normal donor blood. The peripheral blood was
layered with the ficoll and centrifuged at room temperature
(15–25∘C) for 30 minutes at 400×g with brake-off (Ficoll
Paque Plus Instruction Protocol 2007). The mononuclear
cells in the buffy layer were collected and washed with
Phosphate Buffer Saline (PBS) before incubation with TH
for 24 hours at increasing concentrations. These treated
mononuclear cells were stained with Monoclonal Anti-
Human CD14 to ensure the purity and percentage of CD 14+
mononuclear cells.TheCD14 antigen is strongly expressed on
monocytes and macrophage. It is particularly of interest to
use monocytes as they represent myeloid precursor.
2.3. Cytotoxicity Assay. The aim of this assay was to identify
50% Inhibitory Concentration (IC
50
) of treated cell in this
study. The cytotoxicity assay was performed using CytoTox
96 Non-Radioactive Cytotoxicity Assay Kit (Promega, USA).
The CytoTox 96 Assay quantitatively measures lactate dehy-
drogenase (LDH), a stable cytosolic enzyme that is released
upon cell lysis. This LDH assay was performed on K562 and
MV4-11 cell lines and mononuclear cells which were treated
with TH at increasing concentration and time at 0.1%, 0.2%,
0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, and 1.0% (v/v)
for 12 hours, 18 hours, 24 hours, and 48 hours. After the
incubation, the supernatant was collected and then incubated
in the dark place for 30 minutes. Finally the absorbent was
read by using Microplate Elisa Reader.
2.4. Morphologic Studies of Cell Line. Morphologic studies
using the normal inverted microscope were carried out to
observe the morphologic changes of cell death in K562 cell
lines elicited by TH. The stage of morphological changes via
apoptosis was captured.
2.5. Assessment of Apoptosis. Based on cytotoxicity assay,
IC
50
was identified at 24 hours. Harvested K562 and MV4-
11 cell lines and mononuclear cells were incubated in 95% air
humidity; carbon dioxide (CO
2
) 5%; and consistency of tem-
perature at 37.0∘C Then they were incubated with increased
concentrations of Tualang Honey for 24 hours. After incu-
bation, the cells were processed using Annexin V Apoptosis
Detection Kit. The Apoptosis kit contained Annexin V-FITC
and Propidium Iodide (PE) (BD Biosciences, San Jose, CA).
At each identified concentration of TH and at different
incubation times, 1 × 105 cells from culture medium were
isolated, washed with ice cold phosphate buffer solution,
resuspended in 100 𝜇L binding buffer, and stained with 5𝜇L
of FITC-conjugated Annexin V (10mg/mL) and 10 𝜇L of PI
(50mg/mL). The cells were incubated for 15 minutes at room
temperature in the dark, followed by the additional of 400 𝜇L
of binding buffer.
Finally the cells were analyzed by a FACScan flow
cytometry (Becton-Dickinson, Franklin Lakes, NJ USA). For
analysis, K562 and MV4-11 cell lines were gated according
to their granularity and size on forward scatter versus side
scatter plot. Early apoptosis and late apoptosis were evaluated
on fluorescence 2 (FL2 for propidium iodide) versus fluo-
rescence 1 (FL1 for Annexin) plots. The percentage of cells
stainedwithAnnexinVonlywas evaluated as early apoptosis,
while the percentage of cells stainedwith bothAnnexinV and
propidium iodide were evaluated as late apoptosis or necrotic
stage.
2.6. Statistical Analysis. Data were obtained from at least
three independent experiments. The significance of differ-
ence was evaluated using Wilcoxon signed-rank test. A
probability level of 𝑝 < 0.05 was considered as statistically
significant.
3. Result
3.1. Morphologic Changes by Light Microscopy (Figures 1
and 2). Morphologically K562 and MV4-11 cell lines were
homogenous, oval mononuclear cells. After incubation and
treatment with TH, their morphological appearance showed
more rounded cells’ shape, membrane blebbing, formation of
apoptotic body, and finally fragmentation of the cells. These
changes correspond to the apoptotic activity.
3.2. Effect of Tualang Honey on Cell Viability. The impact of
honey on the cell viability was analyzed by cytotoxicity assay.
Exposure of the K562 and MV4-11 cells and mononuclear
cells at different concentrationswith time-dependentmanner
showed significant increase in the production of lactate
dehydrogenase (Figure 3). The dose inducing 50% (IC
50
) cell
growth against normal human mononuclear cells and K562
cell line were determined at 0.6% (18 𝜇L) after 24 hours and
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Figure 1: Photomicrograph of K562 cell line treated with 0.6% (18𝜇L) Tualang Honey at 24 hours. Arrow marks indicate morphology of
K562 cell line and stage of apoptosis. (a) Normal morphology of K562 cell line. (b) Treated K562 cell line shows the membrane blebbing as
activity of early apoptosis. (c) Formation of apoptotic body. (d) Cell lysis: the final stage of apoptosis.
MV4-11 leukemia was determined at 1.2% (33 𝜇L) after 12
hours.
3.3. Assessment of Apoptosis Activity. TH was used to deter-
mine the apoptosis activity for two leukemic lines and a
normal human peripheral blood mononuclear cell. Human
peripheral blood mononuclear cell was used as a control.
The percentage of apoptosis measured before and after
supplement of TH on the normal human peripheral blood
mononuclear cell was 27.7% and 37.4%, respectively (𝑝 >
0.05) (Figure 4). However percentage of apoptosis after
treatment with TH at concentration of 0.6% for leukemia
cell line K562 (53.9%) was significantly higher than normal
mononuclear cells (37.49%) (𝑝 < 0.05). On the other hand,
there was marked reduction in the number of viable cells
between untreated (86.8%) and treated K562 (38.2%) cell
lines (𝑝 < 0.05) (Figure 5). Similarly for MV4-11 cell
line, the apoptosis activity showed dose-dependent manner
(Figure 6). At concentrations of 1.1%, 1.2%, and 1.3% of TH,
the percentage of apoptosis was 48.3%, 50.6%, and 51.9%,
respectively. Quantitative analysis using Annexin V/PI assay
showed increase in both early and late apoptosis of K562 and
MV4-11 cell lines after treatment with TH.
4. Discussion
In Southeast Asia, three types of honey bees can be found in
farm, forest, and villages. The type of honey that was used in
our study was THwhich has been produced by the forest bees
on the branches of theTualang tree, Asia’s tallest tree (growing
up to 80 meters high). The Tualang tree grows in the lowland
rainforests of southernThailand, PeninsularMalaysia,North-
eastern Sumatra, Borneo, and Palawan. Physicochemical
properties of TH are dark brown appearance; pHwas 3.55 and
specific gravity 1.335. TH contains higher content of phenolic
acids, flavonoids, and 5-(hydroxymethyl) furfural (HMF)
than other local Malaysian honeys. A total of six phenolic
acids (gallic, syringic, benzoic, transcinnamic, p-coumaric,
and caffeic acids) and five flavonoids (catechin, kaempferol,
naringenin, luteolin, and apigenin) are found in TH [4].
Hydrocarbons constitute more than half (58.5%) of its com-
position. These include alcohols, ketones, aldehydes, furans,
terpenes, flavonoids, and phenols. Some compounds found in
TH previously not reported in other honeys are stearic acids,
2-cyclopentene-1,4,-dione, 2[3H]-furanone or dihydro-
butyrolactone, gamma-crotonolactone or 2[5H]-furanone,
2-hydroxy-2-cyclopenten-1-one, hyacinthine, 2,4-dihydroxy-
2,5-dimethyl-3[2H]-furan-3-one, and phenylethanol [8].
To date there is limited study on the effect of honey on
leukemia cell lines.Most studies using honey were performed
on solid cancers and showed anticancer properties. In this
study, the cytotoxic and apoptotic effects of honey on K562
and MV4-11 leukemia cell line were investigated. K562
is a chronic myeloid leukemia cell line with a molecular
phenotype bcr/abl gene fusion transcript while MV4-11 is
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Figure 2: Photomicrograph of MV4-II cell line treated with 1.2% (33 𝜇L) Tualang Honey at 12 hours. Arrow marks indicate morphology of
MV4-II cell line and stage of apoptosis. (a) Normal morphology MV4-II cell line. (b) Treated MV4-II cell line shows the membrane blebbing
as activity of early apoptosis. (c) Formation of apoptotic body.
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Figure 3: Viability of K562 and MV4-11 cell lines after treatment with Tualang Honey at various concentrations and time points. (a) IC
50
for
K562 cell line was at 0.6% concentration of honey after 24 hours of incubation. (b) IC
50
for MV4-11 cell line at 12 hours with concentration of
1.2%.
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Figure 4: Flow cytometry analysis. (a) Untreated mononuclear cell (control) stained with Mononuclear Anti-Human CD14. (b) Treated
mononuclear cell with 0.6% of Tualang Honey. Q4 is a region representing cells undergoing apoptosis while Q3 contains viable cells.
Q1 Q2
10
2
10
3
10
4
10
5
PE
-A
10
3
10
2
10
5
10
4
FITC-A
(a)
Q1 Q2
10
5
10
2
10
3
10
4
FITC-A
10
2
10
3
10
4
10
5
PE
-A
(b)
Figure 5: Flow cytometry analysis. (a) Untreated K562 cell line. Viable cells are 86.8%. (b) Treated K562 cell line with 0.6% of Tualang Honey.
Viable cells are 38.2%. Q2 and Q4 represent cells undergoing apoptosis and stained with Propidium Iodide and Annexin while Q3 contains
viable cells.
a myelomonocytic leukemia having inversion 16 karyotype.
The ability to induce cell apoptosis is an important prop-
erty for antileukemic effect. Cell death or apoptosis can
be induced by any highly concentrated materials through
the mechanism of osmosis by making the cell membrane
permeable to water and causing cancer cells to swell and die.
TH has high sugar content of 30% and produces an osmosis
effect [9]. In order to provide evidence and control the
condition, blood monocytes and macrophage from normal
human mononuclear cells were isolated and incorporated
into the study as control cells. This study has proved that TH
did not significantly cause apoptosis on the normal cells as
activity before and after supplement of TH was 27.7% and
37.4%, respectively (𝑝 > 0.05%).
On the other hand, there was a significant difference
on the percentage of apoptosis between K562, MV4-11, and
normal mononuclear cells with activity of 53.9%, 50.6%, and
37.4%, respectively (𝑝 < 0.05), using TH. It can be concluded
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Figure 6: Flow cytometry analysis. (a) TreatedMV4-11 cell line with camptothecin as a control. (b) TreatedMV4-11 cell line with 1.1% (33𝜇L)
of Tualang Honey. (c) Treated MV4-11 cell line with 1.2% (36𝜇L) of Tualang Honey. (d) Treated MV4-11 cell line with 1.3% (39𝜇L) of Tualang
Honey. (a), (b), (c), and (d) have been treated for 12 h. Q2 and Q4 represent cells undergoing apoptosis and stained with Propidium Iodide
and Annexin while Q3 contains viable cells and stained with Propidium Iodide and Annexin V.
that TH has greater potential as apoptosis induces agent for
myeloid leukemia cells.
Apoptosis is characterized by distinct morphologic fea-
tures, including chromatic condensation, cell and nuclear
shrinkage, membrane blebbing, and oligonucleosomal DNA
fragmentation. The apoptosis was confirmed by Annexin V
(apoptosis detection kit) after exposure to TH. In this study
the apoptosis of leukemia cell lines was prominent during
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the late stage exhibited by double positive cells by Annexin/PI
in comparison to normal humanmononuclear cell, where the
apoptosis was at the early stage.
The apoptosis activity could be attributed by few pos-
sible compounds such as flavonoids. One of its chemical
structures, namely, quercetin, has been reported to inhibit
pancreatic and breast cancer cell growth and induce apoptosis
via Bcl-2 expression downregulation and upregulation of Bax
expression [10, 11].
Myeloid leukemia either AML or CML is a group of
malignant disorders characterized by uncontrolled prolifera-
tion of clonal hematopoietic precursor cells associated with
impairment of normal hematopoiesis. Approximately 50–
75% of adult patients with AML achieve complete remission
when treated with cytarabine and daunorubicin or idarubicin
[12]. This chemotherapy induces cell death by apoptosis
mainly mediated through the intrinsic mitochondrial path-
way but also through the extrinsic death receptor pathway,
both of which lead to caspase activation and cell death. The
mode of action by caspases either acts as initiator caspases
(which include caspases 8, 2, 9, and 10) or effector caspases
(caspases 3, 6, and 7). The initiator acts at the early phase of
apoptotic process, while the effector acts at the late stage.
The role of apoptosis in the pathogenesis of AML has
been elucidated over the past years. Some fusion proteins
interact with mediators of apoptosis, sending antiapoptotic
signals that favor the growth of leukemic cells: PML/RAR-𝛼
through the p53 pathway or AML1/ETO through the Bcl2-
related pathway. These mediators are responsible towards
chemoresistance and as such new compounds are required to
induce the apoptosis of leukemic cells.The treatment strategy
of any new compound aims to selectively target and kill the
leukemia cells with no or limited collateral damage to normal
hematopoietic progenitor cells.
Our study has shown that TH has the capacity to induce
apoptosis of both myeloid leukemia cell lines with minimal
effect on the normal mononuclear cells.
Interestingly TH induced a greater extend of apoptosis
in acute myeloid leukemia (MV4-II) compared to chronic
myeloid leukemia (K562). Future study is required to under-
stand the mechanism of apoptosis underlying both types
of myeloid leukemia. As natural product, TH has a great
potential to serve as antileukemic agents.
5. Conclusion
This study has proved that TH did produce a significant
apoptosis effect on both acute and chronic leukemia cell
lines. Thus we conclude that TH could potentially serve as
an antileukemic agent with the apoptosis properties.
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